A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 28 (1), 213-220
- https://doi.org/10.1016/0360-3016(94)90160-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313Cancer, 1992
- Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851Seminars in Radiation Oncology, 1992
- Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin CInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: Preliminary report of radiation therapy oncology group protocol 83-13International Journal of Radiation Oncology*Biology*Physics, 1990
- Adjuvant chemotherapy for advanced head and neck squamous carcinomaCancer, 1987
- Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG studyCancer, 1987
- The significance of anemia in clinical radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum(II) and irradiationRadiotherapy and Oncology, 1986
- Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X raysInternational Journal of Radiation Oncology*Biology*Physics, 1982